Literature DB >> 13692356

Respiratory disease in volunteers infected with Eaton agent: a preliminary report.

R M CHANOCK, D RIFKIND, H M KRAVETZ, V KINGHT, K M JOHNSON.   

Abstract

Entities:  

Keywords:  RESPIRATORY TRACT INFECTIONS/experimental

Mesh：

Year:  1961        PMID： 13692356      PMCID： PMC221357          DOI： 10.1073/pnas.47.6.887

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  8 in total

1.  Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1).

Authors:  D A TYRRELL; M L BYNOE; K B PETERSEN; R N SUTTON; M S PEREIRA
Journal:  Br Med J       Date:  1959-11-07

2.  Infection of human volunteers with type 2 hemadsorption virus.

Authors:  T E REICHELDERFER; R M CHANOCK; J E CRAIGHEAD; R J HUEBNER; H C TURNER; W JAMES; T G WARD
Journal:  Science       Date:  1958-10-03       Impact factor: 47.728

3.  Eaton agent pneumonia.

Authors:  R M CHANOCK; M A MUFSON; H H BLOOM; W D JAMES; H H FOX; J R KINGSTON
Journal:  JAMA       Date:  1961-01-21       Impact factor: 56.272

4.  Growth of laboratory and naturally occurring strains of Eaton agent in monkey kidney tissue culture.

Authors:  R M CHANOCK; H H FOX; W D JAMES; H H BLOOM; M A MUFSON
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

5.  The vacuolating virus, S.V. 40.

Authors:  B H SWEET; M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

6.  Eaton agent pneumonia.

Authors:  J R KINGSTON; R M CHANOCK; M A MUFSON; L P HELLMAN; W D JAMES; H H FOX; M A MANKO; J BOYERS
Journal:  JAMA       Date:  1961-04-15       Impact factor: 56.272

7.  Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood.

Authors:  R M CHANOCK; M K COOK; H H FOX; R H PARROTT; R J HUEBNER
Journal:  N Engl J Med       Date:  1960-03-31       Impact factor: 91.245

8.  Studies on primary atypical pneumonia. II. Observations concerning the development and immunological characteristics of antibody in patients.

Authors:  C LIU; M D EATON; J T HEYL
Journal:  J Exp Med       Date:  1959-06-01       Impact factor: 14.307
  8 in total
  22 in total

1.  STUDIES ON EATON PPLO PNEUMONIA.

Authors:  E JANSSON; O WAGER; R STENSTROEM; E KLEMOLA; P FORSSEL
Journal:  Br Med J       Date:  1964-01-18

Review 2.  UNDERSTANDING OF VIRAL RESPIRATORY ILLNESSES PROVIDED BY EXPERIMENTS IN VOLUNTEERS.

Authors:  G G JACKSON
Journal:  Bacteriol Rev       Date:  1964-12

3.  Infection with Eaton's primary atypical pneumonia agent in England.

Authors:  G M GOODBURN; B P MARMION; E J KENDALL
Journal:  Br Med J       Date:  1963-05-11

4.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

5.  Disulfide-linked protein associated with Mycoplasma pneumoniae cytadherence phase variation.

Authors:  M K Stevens; D C Krause
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Acute respiratory diseases of viral etiology. V. Eaton agent: a review.

Authors:  M A MUFSON; H H BLOOM; M A MANKO; J R KINGSTON; R M CHANOCK
Journal:  Am J Public Health Nations Health       Date:  1962-06

Review 7.  [Mycoplasma (PPL organisms and their clinical importance)].

Authors:  F J Bassermann
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1967

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 9.  Respiratory diseases among U.S. military personnel: countering emerging threats.

Authors:  G C Gray; J D Callahan; A W Hawksworth; C A Fisher; J C Gaydos
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

Review 10.  Mycoplasma pneumoniae infections of adults and children.

Authors:  J D Cherry; R C Welliver
Journal:  West J Med       Date:  1976-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.